Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Other financing activities (2023 - 2026)

Bausch & Lomb's (BLCO) quarterly Other financing activities came in at $2.0 million in Q1 2026, up 200.0% on a QoQ basis from -$2.0 million in Q4 2023.

Bausch & Lomb (BLCO) Other financing activities (2023 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 2 years of Other financing activities data on file, last reported at $2.0 million in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 million (up 200.0% YoY) and the FY2024 annual result came in at -$1.0 million, up 50.0% from the prior year.
  • Other financing activities rose to $2.0 million in Q1 2026, from -$2.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.0 million in Q1 2026 to a low of -$2.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Mar 31, 2026 2.00 Mn
Dec 31, 2023 -2.00 Mn
Dec 31, 2023 -2.00 Mn